CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 167 enrolled
Drug / intervention
Wellframeother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03416920
NCT03416920N/ACompleted

A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk

Massachusetts General Hospital·interventional·Posted Jan 31, 2018·Updated Jul 17, 2023

In Brief

A clinical study evaluating Wellframe for Percutaneous Coronary Intervention. Completed, enrolled 167 participants across 2 sites.

Detailed Summary

The investigators aim to evaluate Wellframe, a patient engagement platform that includes a mobile phone application for patients, for its impact on supporting patients who have undergone a percutaneous coronary intervention. The patient mobile app has articles about cardiovascular disease and other health related topics, patient-reported outcomes surveys, physical activity tracking, reminders for medications and upcoming appointments, and two-way communication with a Wellframe Health Advocate. The Wellframe Health Advocate encourages patients to achieve their health goals and stay engaged in their health. The feasibility of onboarding patients to the app and the clinical efficacy of the platform will be evaluated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 31, 2018
Enrollment StartFeb 12, 2018
Primary CompletionAug 20, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.4 years ago

Interventions

Wellframeother

Wellframe mobile phone app